B. Inceoğlu

发表

Antigenic Cross-Reactivity Anti-Birtoxin Antibody against Androctonus crassicauda Venom

O. Ozkan, Suhandan Adigüzel Van Zoelen, B. Inceoğlu, 2015, Journal of arthropod-borne diseases.

Evaluation of the neutralizing capacity of Androctonus crassicauda (Olivier, 1807) antivenom against Leiurus quinquestriatus (Ehrenberg, 1928) venom (Scorpiones: Buthidae)

B. Hammock, J. Lango, O. Ozkan, 2008 .

The neutralizing effect of a polyclonal antibody raised against the N-terminal eighteen-aminoacid residues of birtoxin towards the whole venom of Parabuthus transvaalicus.

B. Hammock, J. Lango, Alina Rabinovich, 2006, Toxicon : official journal of the International Society on Toxinology.

Isolation and characterization of a novel type of neurotoxic peptide from the venom of the South African scorpion Parabuthus transvaalicus (Buthidae).

P. Hawkins, B. Hammock, J. Lango, 2001, European journal of biochemistry.

Development of an ultra fast online-solid phase extraction (SPE) liquid chromatography electrospray tandem mass spectrometry (LC-ESI-MS/MS) based approach for the determination of drugs in pharmacokinetic studies.

B. Hammock, N. Schebb, Tristan E. Rose, 2011, Analytical methods : advancing methods and applications.

Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.

S. Goswami, Jun Yang, B. Hammock, 2015, Toxicology and applied pharmacology.

Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.

F. Haj, A. Gomes, B. Hammock, 2017, Prostaglandins & other lipid mediators.

Soluble Epoxide Hydrolase Inhibition and Epoxyeicosatrienoic Acid Treatment Improve Vascularization of Engineered Skin Substitutes

D. Supp, S. Boyce, B. Hammock, 2016, Plastic and reconstructive surgery. Global open.

Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model

O. Fiehn, R. Weiss, B. Hammock, 2008, Journal of cardiovascular pharmacology.

The Effect of p.Arg25Cys Alteration in NKX2-5 on Conotruncal Heart Anomalies: Mutation or Polymorphism?

M. Tekin, B. Inceoğlu, S. Atalay, 2007, Pediatric Cardiology.

Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.

Jun Yang, B. Hammock, B. Inceoğlu, 2014, The journal of pain : official journal of the American Pain Society.

SolubleEpoxideHydrolaseInhibitionIsAntinociceptiveinaMouse Model of Diabetic Neuropathy

Jun Yang, B. Hammock, B. Inceoğlu, 2014 .

Soluble epoxide hydrolase pharmacological inhibition decreases alveolar bone loss by modulating host inflammatory response , RANK-related signaling , ER stress and apoptosis *

F. Haj, S. Goswami, B. Hammock, 2017 .

Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis

F. Haj, S. Goswami, B. Hammock, 2017, The Journal of Pharmacology and Experimental Therapeutics.

The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling.

B. Hammock, B. Inceoğlu, K. Wagner, 2014, Prostaglandins & other lipid mediators.

Prostaglandins and Other Lipid Mediators eview he role of long chain fatty acids and their epoxide metabolites in ociceptive signaling

B. Hammock, B. Inceoğlu, Stephen T. Vito, 2014 .

Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids[S]

B. Hammock, K. Schmelzer, C. Morisseau, 2010, Journal of Lipid Research.

Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP

B. Hammock, C. Morisseau, R. Brosnan, 2011, Proceedings of the National Academy of Sciences.

Lipidomes of brain from rats acutely intoxicated with diisopropylfluorophosphate identifies potential therapeutic targets.

Jun Yang, B. Hammock, Chang Wang, 2019, Toxicology and applied pharmacology.

Therapeutic activity of inhibition of the soluble epoxide hydrolase in a mouse model of scrapie.

S. Hwang, P. Dall’Ara, B. Hammock, 2013, Life sciences.

Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain.

B. Hammock, K. Schmelzer, S. Jinks, 2006, Life sciences.

Sensitive Immunoassay for Detection and Quantification of the Neurotoxin, Tetramethylenedisulfotetramine.

B. Hammock, S. Gee, N. Vasylieva, 2017, Analytical chemistry.

Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption

F. Haj, B. Hammock, M. Napimoga, 2018, Journal of periodontal research.

Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive.

D. Piomelli, B. Hammock, C. Morisseau, 2015, Pharmacological research.

Epidemiological and clinical characteristics of scorpionism in children in Sanliurfa, Turkey.

O. Ozkan, B. Inceoğlu, S. Adiguzel, 2007, Toxicon : official journal of the International Society on Toxinology.

Further enhancement of baculovirus insecticidal efficacy with scorpion toxins that interact cooperatively

B. Hammock, N. Chejanovsky, M. Gurevitz, 2003, FEBS Letters.

Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception.

B. Hammock, B. Inceoğlu, K. Wagner, 2011, Prostaglandins & other lipid mediators.

Prostaglandins and Other Lipid Mediators eview oluble epoxide hydrolase inhibition , epoxygenated fatty acids and nociception

B. Hammock, B. Inceoğlu, A. Wagner, 2011 .

Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures

N. Alkayed, Jun Yang, B. Hammock, 2011, Journal of neurochemistry.

Effect of a Soluble Epoxide Hydrolase Inhibitor, UC1728, on LPS-Induced Uveitis in the Rabbit

S. Hwang, Jun Yang, B. Hammock, 2016, Journal of ocular biology.

Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication.

M. Rogawski, D. Tancredi, B. Hammock, 2014, Toxicology and applied pharmacology.

Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain

F. Haj, B. Hammock, K. S. Lee, 2015, Proceedings of the National Academy of Sciences.

Potent Natural Soluble Epoxide Hydrolase Inhibitors from Pentadiplandra brazzeana Baillon: Synthesis, Quantification, and Measurement of Biological Activities In Vitro and In Vivo

B. Hammock, C. Morisseau, M. Nyegue, 2015, PloS one.

Epoxy Fatty Acids and Inhibition of the Soluble Epoxide Hydrolase Selectively Modulate GABA Mediated Neurotransmission to Delay Onset of Seizures

S. Hwang, M. Rogawski, Jun Yang, 2013, PloS one.

Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models.

Paul D. Jones, S. Hwang, Jun Yang, 2013, European journal of pharmacology.

Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes

F. Haj, S. Hwang, Jun Yang, 2012, Proceedings of the National Academy of Sciences.

The soluble epoxide hydrolase as a pharmaceutical target for pain management.

B. Hammock, B. Inceoğlu, K. Wagner, 2011, Pain management.

1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain.

Paul D. Jones, B. Hammock, C. Morisseau, 2010, Journal of medicinal chemistry.

Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers

S. Goswami, Jun Yang, B. Hammock, 2016, The Journal of Pharmacology and Experimental Therapeutics.

Inhibition of soluble epoxide hydrolase as a novel approach to high dose diazepam induced hypotension.

H. Wulff, Jun Yang, B. Hammock, 2016, Journal of clinical toxicology.

LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide.

B. Hammock, C. Morisseau, A. Rand, 2018, Methods in molecular biology.

TRPV1 Channels Are Involved in Niacin-induced Cutaneous Vasodilation in Mice

Linlin Ma, Jie Zheng, S. Schaefer, 2014, Journal of cardiovascular pharmacology.

Isolation and characterization of a novel lepidopteran-selective toxin from the venom of South Indian red scorpion, Mesobuthus tamulus

P. Choudary, B. Hammock, B. Inceoğlu, 2001, BMC Biochemistry.

One scorpion, two venoms: Prevenom of Parabuthus transvaalicus acts as an alternative type of venom with distinct mechanism of action

B. Hammock, I. Pessah, J. Lango, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Combined treatment with diazepam and allopregnanolone reverses tetramethylenedisulfotetramine (TETS)-induced calcium dysregulation in cultured neurons and protects TETS-intoxicated mice against lethal seizures

M. Rogawski, D. Tancredi, B. Hammock, 2015, Neuropharmacology.

Characterization of Seizures Induced by Acute and Repeated Exposure to Tetramethylenedisulfotetramine

Mark R. McCoy, M. Rogawski, B. Hammock, 2012, Journal of Pharmacology and Experimental Therapeutics.

Investigation of human exposure to triclocarban after showering and preliminary evaluation of its biological effects.

B. Hammock, C. Morisseau, K. Ahn, 2011, Environmental science & technology.

Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways

Paul D. Jones, B. Hammock, K. Schmelzer, 2008, Proceedings of the National Academy of Sciences.

Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

Bruce D Hammock, B. Hammock, K. Schmelzer, 2007, Prostaglandins & other lipid mediators.

Epoxygenated fatty acids and soluble epoxide hydrolase inhibition: novel mediators of pain reduction.

B. Hammock, S. Gill, B. Inceoğlu, 2011, Journal of agricultural and food chemistry.

Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors

B. Hammock, K. Schmelzer, J. Eiserich, 2006, Proceedings of the National Academy of Sciences.

Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.

F. Haj, D. Zeldin, A. Gruzdev, 2017, Biochimica et biophysica acta. General subjects.

Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase.

J. German, S. Watkins, M. Wiest, 2009, American journal of physiology. Endocrinology and metabolism.

Effect of a Soluble Epoxide Hydrolase Inhibitor , UC 1728 , on LPS-Induced Uveitis in the Rabbit Abbreviations

S. Hwang, Jun Yang, B. Hammock, 2016 .

Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model.

S. Hwang, Jun Yang, B. Hammock, 2010, Biochemical pharmacology.

Occurrence of urea-based soluble epoxide hydrolase inhibitors from the plants in the order Brassicales

B. Hammock, C. Morisseau, B. Inceoğlu, 2017, PloS one.

Inhibitors of soluble epoxide hydrolase minimize ischemia‐reperfusion‐induced cardiac damage in normal, hypertensive, and diabetic rats

S. Hwang, S. Goswami, B. Hammock, 2017, Cardiovascular therapeutics.

Epoxyeicosanoids promote organ and tissue regeneration

Hau D. Le, D. Ingber, K. Tomer, 2013, Proceedings of the National Academy of Sciences.

Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia.

M. Tekin, N. Akar, H. Özdağ, 2007, American journal of human genetics.

Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac‐induced gastric ulcers

S. Goswami, Jun Yang, B. Hammock, 2017, Life sciences.

Soluble epoxide hydrolase inhibitors are first in class therapeutic candidates for chronic and intractable pain in man and companion animals (1061.4)

B. Inceoğlu, 2014 .

Comparative efficacy of 3 soluble epoxide hydrolase inhibitors in rat neuropathic and inflammatory pain models.

Paul D. Jones, S. Hwang, Jun Yang, 2013, European journal of pharmacology.

Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis

F. Haj, S. Goswami, B. Hammock, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures

P. Lein, Donald A. Bruun, B. Inceoğlu, 2011, Journal of neurochemistry.